The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

NCT04644185 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

102

Enrollment

INDUSTRY

Sponsor class

Stopped Preclinical test showed reduced efficacy

Conditions

Covid19

Interventions

DRUG: SCTA01
OTHER: Placebo

Sponsor

Sinocelltech Ltd.